Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Myasthenia Gravis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Myasthenia Gravis Drugsmarket, defines the market attractiveness level of Myasthenia Gravis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Myasthenia Gravis Drugs industry, describes the types of Myasthenia Gravis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Myasthenia Gravis Drugs market and the development prospects and opportunities of Myasthenia Gravis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Myasthenia Gravis Drugs market in Chapter 13.
By Player:
Novartis
GlaxoSmithKline
Alexion
Mitsubishi Tanabe Pharma
Grifols
Curavac
Roche
Pfizer
Flamel Technologies
Lupin Pharmaceuticals
Cytokinetics
CSL
Catalyst
Shire
Galencia
Valeant
By Type:
Anticholinesterases
Immunosuppressants
Intravenous Immune Globulins
By End-User:
Intravenous Immune Globulins
Intravenous Immune Globulins
Intravenous Immune Globulins
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Myasthenia Gravis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Myasthenia Gravis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Myasthenia Gravis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Myasthenia Gravis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Myasthenia Gravis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.2 United States Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.3 Europe Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.4 China Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.5 Japan Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.6 India Myasthenia Gravis Drugs Consumption (2017-2022)
-
7.7 South Korea Myasthenia Gravis Drugs Consumption (2017-2022)
8 Region and Country-wise Myasthenia Gravis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.4 China Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.6 India Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Myasthenia Gravis Drugs Consumption Forecast (2022-2028)
9 Global Myasthenia Gravis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Myasthenia Gravis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anticholinesterases Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunosuppressants Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
9.2 Global Myasthenia Gravis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
10 Global Myasthenia Gravis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Myasthenia Gravis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anticholinesterases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunosuppressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Myasthenia Gravis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
11 Global Myasthenia Gravis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Myasthenia Gravis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Myasthenia Gravis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Myasthenia Gravis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Myasthenia Gravis Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Myasthenia Gravis Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Myasthenia Gravis Drugs Product and Service
-
14.3 Alexion
-
14.3.1 Alexion Company Details
-
14.3.2 Alexion Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alexion Myasthenia Gravis Drugs Product and Service
-
14.4 Mitsubishi Tanabe Pharma
-
14.4.1 Mitsubishi Tanabe Pharma Company Details
-
14.4.2 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Product and Service
-
14.5 Grifols
-
14.5.1 Grifols Company Details
-
14.5.2 Grifols Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Grifols Myasthenia Gravis Drugs Product and Service
-
14.6 Curavac
-
14.6.1 Curavac Company Details
-
14.6.2 Curavac Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Curavac Myasthenia Gravis Drugs Product and Service
-
14.7 Roche
-
14.7.1 Roche Company Details
-
14.7.2 Roche Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Roche Myasthenia Gravis Drugs Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Myasthenia Gravis Drugs Product and Service
-
14.9 Flamel Technologies
-
14.9.1 Flamel Technologies Company Details
-
14.9.2 Flamel Technologies Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Flamel Technologies Myasthenia Gravis Drugs Product and Service
-
14.10 Lupin Pharmaceuticals
-
14.10.1 Lupin Pharmaceuticals Company Details
-
14.10.2 Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Lupin Pharmaceuticals Myasthenia Gravis Drugs Product and Service
-
14.11 Cytokinetics
-
14.11.1 Cytokinetics Company Details
-
14.11.2 Cytokinetics Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Cytokinetics Myasthenia Gravis Drugs Product and Service
-
14.12 CSL
-
14.12.1 CSL Company Details
-
14.12.2 CSL Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 CSL Myasthenia Gravis Drugs Product and Service
-
14.13 Catalyst
-
14.13.1 Catalyst Company Details
-
14.13.2 Catalyst Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Catalyst Myasthenia Gravis Drugs Product and Service
-
14.14 Shire
-
14.14.1 Shire Company Details
-
14.14.2 Shire Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Shire Myasthenia Gravis Drugs Product and Service
-
14.15 Galencia
-
14.15.1 Galencia Company Details
-
14.15.2 Galencia Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Galencia Myasthenia Gravis Drugs Product and Service
-
14.16 Valeant
-
14.16.1 Valeant Company Details
-
14.16.2 Valeant Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Valeant Myasthenia Gravis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Myasthenia Gravis Drugs
-
Figure Myasthenia Gravis Drugs Picture
-
Table Global Myasthenia Gravis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Myasthenia Gravis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Myasthenia Gravis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Myasthenia Gravis Drugs Consumption by Country (2017-2022)
-
Figure United States Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Myasthenia Gravis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Myasthenia Gravis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Myasthenia Gravis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticholinesterases Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppressants Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immune Globulins Consumption and Growth Rate (2017-2022)
-
Figure Global Anticholinesterases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immune Globulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Myasthenia Gravis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Myasthenia Gravis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Myasthenia Gravis Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Myasthenia Gravis Drugs Product and Service
-
Table Alexion (Foundation Year, Company Profile and etc.)
-
Table Alexion Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Myasthenia Gravis Drugs Product and Service
-
Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Myasthenia Gravis Drugs Product and Service
-
Table Curavac (Foundation Year, Company Profile and etc.)
-
Table Curavac Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curavac Myasthenia Gravis Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Myasthenia Gravis Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Myasthenia Gravis Drugs Product and Service
-
Table Flamel Technologies (Foundation Year, Company Profile and etc.)
-
Table Flamel Technologies Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Flamel Technologies Myasthenia Gravis Drugs Product and Service
-
Table Lupin Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Pharmaceuticals Myasthenia Gravis Drugs Product and Service
-
Table Cytokinetics (Foundation Year, Company Profile and etc.)
-
Table Cytokinetics Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytokinetics Myasthenia Gravis Drugs Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Myasthenia Gravis Drugs Product and Service
-
Table Catalyst (Foundation Year, Company Profile and etc.)
-
Table Catalyst Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst Myasthenia Gravis Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Myasthenia Gravis Drugs Product and Service
-
Table Galencia (Foundation Year, Company Profile and etc.)
-
Table Galencia Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galencia Myasthenia Gravis Drugs Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Myasthenia Gravis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Myasthenia Gravis Drugs Product and Service
-
